PacBio

PacBio has announced a collaboration with the University of Tokyo to study the use of long-read sequencing and novel bioinformatics methods in the hopes of better understanding the genetic causes of certain rare diseases in individuals and cohorts within the Japanese population.

The assembly and annotation of the genome of the red perilla plant will help scientists harness the plant's wide range bioactive compounds.

PacBio has announced its HiFi sequencing technology will be used in a pilot project for the Children’s Rare Disease Cohorts Initiative (CRDC) at Boston Children’s Hospital.

A novel DNA preparation protocol enables labs to isolate high molecular weight DNA from a variety of plant species cost-effectively and rapidly, opening opportunities to improve the robustness of commercially valuable plants.

This article explores some of the ways genomics can deepen our understanding of the biosphere and how biodiversity genomics contributes to conservation.

PacBio has announced the Revio™ long-read sequencing system, which will enable customers to dramatically scale their use of PacBio’s celebrated HiFi sequencing technology.

PacBio has announced the commencement of external beta testing of the Onso™ Sequencing System.

The genome of the Honeycrisp apple has been sequenced, providing a valuable understanding of the genetic basis of important traits in apples.

In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.

PacBio has announced the availability of a new computational analysis method for profiling more than a million tandem repeats across the human genome using PacBio’s native long-read HiFi sequencing data.